|Day Low/High||58.27 / 59.20|
|52 Wk Low/High||45.69 / 60.07|
The stock is back to an area where sellers could emerge.
Stocks fluctuate on Friday morning as the mix of earnings reports again pulls Wall Street in two directions.
Stock futures are mixed on Friday morning after second-quarter economic growth in the U.S. falls short of economists' expectations.
Alphabet shares rise after the company handily beats quarterly estimates; Amazon's cloud computing business continues to shine; U.S. stock futures point lower.
Merck raises the floor of guidance for full-year non-GAAP earnings per share and is now targeting between $3.67 and $3.77.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced financial results for the second quarter of 2016.
On Friday, July 29, investors will get quarterly results from Anheuser-Busch Inbev and the first estimate of second quarter GDP.
Merck (MRK) stock is slipping this morning as the company expects to post fiscal 2016 second quarter results before tomorrow's market open.
It's too cheap for a biotech giant with years of patent protection for key products and great cash flow.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the Board of Directors has declared a quarterly dividend of $0.
Merck (MRK) announced that its experimental Ebola vaccine V920 has been put under 'accelerated' review in the U.S. and the EU.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced two regulatory milestones for the company's investigational vaccine for Ebola Zaire, V920 (rVSV¿G-ZEBOV-GP, live attenuated): the U.
A slew of corporate earnings and closely watched Federal Reserve meeting are in focus for the week of July 25.
Optimism is warranted over the long haul, but investors probably face a short-term headache. Here are the crucial numbers and events to watch in the week ahead.
The Federal Reserve will steal focus from another onslaught of earnings in the coming week as investors remain wary over the central bank's rate-hike timetable.
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced efficacy and safety data in previously untreated adults with HIV-1 infection for the company's investigational once-daily formulation of...
Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, today announced the U.
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today said that the U.
Earnings season is off to a good start. Here are five more stocks that could shoot higher this summer.
Celgene continues to sprinkle cash around the biotech sector, tying up with smaller companies for first-dibs access to potentially valuable drugs and technologies.
BMO Capital Markets downgrades the pharmaceutical giant ahead of Q2 earnings as pricing pressure mounts and other potential headwinds begin to emerge.
BMO Capital Markets downgraded Merck (MRK) stock to ‘market perform’ today.
Here are Monday's top research calls, including upgrades for Groupon and Humana, and downgrades for Monster Beverage and Merck.
Cramer shares his views on why he thinks this market is not finished. Facebook, Amazon and Netflix are among the stocks discussed.
TheStreet highlights 3 stocks pushing the drugs industry lower today.